Cadre Holdings, Inc. (CDRE) focuses on a straightforward yet vital mission: producing equipment that protects people in high-risk environments. Its lineup includes body armor, bomb suits, duty gear, and specialized tools for explosive ordnance disposal. With customers ranging from police and fire departments to military units, the company sits at the intersection of public safety and defense. I find its mix of established government ties and a dual manufacturing-distribution model worth monitoring, and I also checked this using Tickeron’s AI Screener to see how it stacks up against peers.
Cadre traces its origins to 1964 through the Safariland business, which has long supplied protective gear to law enforcement and military users. Incorporated in Delaware and based in Jacksonville, Florida, the firm employs about 2,500 people and listed on the New York Stock Exchange in November 2021.
It runs two main segments. The Product segment makes and sells its own branded items such as body armor, holsters, and protective gear. The Distribution segment serves as a broader supplier, combining Cadre products with third-party items like uniforms and optics for government buyers. This setup provides both manufacturing margins and wider reach into public-sector markets.
Key brands include Safariland for duty gear, Protech Tactical for armor, and Med-Eng for bomb suits and related equipment. The company also offers survival suits, remote vehicles, blast sensors, and vehicle protection systems. Primary buyers are state and local agencies, federal departments such as Defense, Homeland Security, Justice, and State, plus international governments. Sales occur through direct teams, partners, online channels, and resellers.
Acquisitions have extended Cadre into nuclear, defense, and energy sectors with precision components and handling systems, applying its safety expertise to new areas. From what I see, this expansion adds resilience without straying from core competencies.
Several factors stand out for long-term investors. Products often face recurring, non-discretionary demand as agencies re-equip personnel. Brand reputation and certification barriers help in body armor and gear categories. The acquisition strategy aims to build scale and cross-sell opportunities, while a modest dividend appeals to income-focused holders. Leadership under Chairman and CEO Warren B. Kanders brings experience in specialty industrials. I’m watching this closely as the buy-and-build approach unfolds.
Government budgets introduce sensitivity to spending cycles and policy shifts. Macro conditions and supply-chain issues can also affect results. Debt levels tied to acquisitions warrant attention, along with integration challenges and competitive pressures in protective equipment. As a smaller industrial name, share volatility may exceed that of larger peers. A clear view of operations and finances remains essential before any position.
When evaluating names like this, I often turn to Tickeron’s AI Screener to quickly compare fundamentals, trends, and patterns across the sector. It lets me apply custom filters on technicals, volatility, and industry data, which helps surface ideas that fit a given strategy without hours of manual work. In my view, tools like this support more informed screening before diving into filings or calls.
Cadre Holdings maintains a focused role in safety and survivability equipment for public-safety and defense markets. Its brands, dual-segment model, and moves into adjacent fields create a distinct profile in the space. Government-budget exposure, leverage, and execution risks exist, yet the mission-critical nature of its offerings and growth approach keep the company relevant for those tracking this corner of the industrial landscape.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CDRE saw its Momentum Indicator move above the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In 71 of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at 86%.
CDRE moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CDRE crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 18 of 24 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +5.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where CDRE advanced for three days, in 255 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 214 of 289 cases where CDRE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The 10-day RSI Indicator for CDRE moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 30 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
CDRE broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CDRE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.025) is normal, around the industry mean (5.050). P/E Ratio (37.907) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.012) settles around the average of (0.055) among similar stocks. P/S Ratio (1.720) is also within normal values, averaging (18.367).
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense